Related references
Note: Only part of the references are listed.Discovery and validation of graft-versus-host disease biomarkers
Sophie Paczesny
BLOOD (2013)
Alterations in the Cellular Immune Compartment of Patients Treated with Third-Party Mesenchymal Stromal Cells Following Allogeneic Hematopoietic Stem Cell Transplantation
Regina Jitschin et al.
STEM CELLS (2013)
Long-Term Complications, Immunologic Effects, and Role of Passage for Outcome in Mesenchymal Stromal Cell Therapy
Lena von Bahr et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2012)
Plasma biomarkers of lower gastrointestinal and liver acute GVHD
Andrew C. Harris et al.
BLOOD (2012)
Acute graft-versus-host disease biomarkers measured during therapy can predict treatment outcomes: a Blood and Marrow Transplant Clinical Trials Network study
John E. Levine et al.
BLOOD (2012)
The establishment of a bank of stored clinical bone marrow stromal cell products
Marianna Sabatino et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2012)
Mesenchymal Stromal Cells Do Not Increase the Risk of Viral Reactivation Nor the Severity of Viral Events in Recipients of Allogeneic Stem Cell Transplantation
Giovanna Lucchini et al.
STEM CELLS INTERNATIONAL (2012)
Efficacy and Safety of Ex Vivo Cultured Adult Human Mesenchymal Stem Cells (Prochymal™) in Pediatric Patients with Severe Refractory Acute Graft-Versus-Host Disease in a Compassionate Use Study
Vinod K. Prasad et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2011)
Global transcriptome analysis of human bone marrow stromal cells (BMSC) reveals proliferative, mobile and interactive cells that produce abundant extracellular matrix proteins, some of which may affect BMSC potency
Jiaqiang Ren et al.
CYTOTHERAPY (2011)
Transplantation of ex-vivo culture-expanded parental haploidentical mesenchymal stem cells to promote engraftment in pediatric recipients of unrelated donor umbilical cord blood: results of a phase I-II clinical trial
M. L. MacMillan et al.
BONE MARROW TRANSPLANTATION (2009)
Mesenchymal stem cells in hematopoietic stem cell transplantation
Minoo Battiwalla et al.
CYTOTHERAPY (2009)
HSCT Recipients Have Specific Tolerance to MSC but not to the MSC Donor
Mikael Sundin et al.
JOURNAL OF IMMUNOTHERAPY (2009)
Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease:: a phase II study
Katarina LeBlanc et al.
LANCET (2008)
Tissue repair using allogeneic mesenchymal stem cells for hemorrhagic cystitis, pneumomediastinum and perforated colon
O. Ringden et al.
LEUKEMIA (2007)
Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells
K Le Blanc et al.
LANCET (2004)
Improved survival in steroid-refractory acute graft versus host disease after non-myeloablative allogeneic transplantation using a daclizumab-based strategy with comprehensive infection prophylaxis
R Srinivasan et al.
BRITISH JOURNAL OF HAEMATOLOGY (2004)
Share Paper
